BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 26593443)

  • 21. The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis.
    Muntean AG; Tan J; Sitwala K; Huang Y; Bronstein J; Connelly JA; Basrur V; Elenitoba-Johnson KS; Hess JL
    Cancer Cell; 2010 Jun; 17(6):609-21. PubMed ID: 20541477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcription control by the ENL YEATS domain in acute leukaemia.
    Erb MA; Scott TG; Li BE; Xie H; Paulk J; Seo HS; Souza A; Roberts JM; Dastjerdi S; Buckley DL; Sanjana NE; Shalem O; Nabet B; Zeid R; Offei-Addo NK; Dhe-Paganon S; Zhang F; Orkin SH; Winter GE; Bradner JE
    Nature; 2017 Mar; 543(7644):270-274. PubMed ID: 28241139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling.
    Bitoun E; Oliver PL; Davies KE
    Hum Mol Genet; 2007 Jan; 16(1):92-106. PubMed ID: 17135274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications.
    Milne TA; Martin ME; Brock HW; Slany RK; Hess JL
    Cancer Res; 2005 Dec; 65(24):11367-74. PubMed ID: 16357144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of CpG-Rich Promoters Mediated by MLL Drives MOZ-Rearranged Leukemia.
    Miyamoto R; Okuda H; Kanai A; Takahashi S; Kawamura T; Matsui H; Kitamura T; Kitabayashi I; Inaba T; Yokoyama A
    Cell Rep; 2020 Sep; 32(13):108200. PubMed ID: 32997997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MLL fusion partners AF4 and AF9 interact at subnuclear foci.
    Erfurth F; Hemenway CS; de Erkenez AC; Domer PH
    Leukemia; 2004 Jan; 18(1):92-102. PubMed ID: 14603337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frat2 mediates the oncogenic activation of Rac by MLL fusions.
    Walf-Vorderwülbecke V; de Boer J; Horton SJ; van Amerongen R; Proost N; Berns A; Williams O
    Blood; 2012 Dec; 120(24):4819-28. PubMed ID: 23074275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A reconfigured pattern of MLL occupancy within mitotic chromatin promotes rapid transcriptional reactivation following mitotic exit.
    Blobel GA; Kadauke S; Wang E; Lau AW; Zuber J; Chou MM; Vakoc CR
    Mol Cell; 2009 Dec; 36(6):970-83. PubMed ID: 20064463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Polymerase-Associated Factor complex (PAFc) connects the Super Elongation Complex (SEC) to RNA polymerase II on chromatin.
    He N; Chan CK; Sobhian B; Chou S; Xue Y; Liu M; Alber T; Benkirane M; Zhou Q
    Proc Natl Acad Sci U S A; 2011 Sep; 108(36):E636-45. PubMed ID: 21873227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting recruitment of disruptor of telomeric silencing 1-like (DOT1L): characterizing the interactions between DOT1L and mixed lineage leukemia (MLL) fusion proteins.
    Shen C; Jo SY; Liao C; Hess JL; Nikolovska-Coleska Z
    J Biol Chem; 2013 Oct; 288(42):30585-30596. PubMed ID: 23996074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The RNA-binding protein IGF2BP3 is critical for MLL-AF4-mediated leukemogenesis.
    Tran TM; Philipp J; Bassi JS; Nibber N; Draper JM; Lin TL; Palanichamy JK; Jaiswal AK; Silva O; Paing M; King J; Katzman S; Sanford JR; Rao DS
    Leukemia; 2022 Jan; 36(1):68-79. PubMed ID: 34321607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
    Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
    Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reconstitution of human rRNA gene transcription in mouse cells by a complete SL1 complex.
    Murano K; Okuwaki M; Momose F; Kumakura M; Ueshima S; Newbold RF; Nagata K
    J Cell Sci; 2014 Aug; 127(Pt 15):3309-19. PubMed ID: 24928901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia.
    Germano G; Morello G; Aveic S; Pinazza M; Minuzzo S; Frasson C; Persano L; Bonvini P; Viola G; Bresolin S; Tregnago C; Paganin M; Pigazzi M; Indraccolo S; Basso G
    Oncotarget; 2017 Apr; 8(16):26129-26141. PubMed ID: 28412727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TGFβ/SMAD signalling modulates MLL and MLL-AF4 mediated 5-lipoxygenase promoter activation.
    Saul MJ; Groher F; Hegewald AB; Müller-McNicoll M; Marschalek R; Suess B; Steinhilber D
    Prostaglandins Other Lipid Mediat; 2017 Nov; 133():60-67. PubMed ID: 28803964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of AF4 wild-type and AF4.MLL fusion protein with SIAH proteins: indication for t(4;11) pathobiology?
    Bursen A; Moritz S; Gaussmann A; Moritz S; Dingermann T; Marschalek R
    Oncogene; 2004 Aug; 23(37):6237-49. PubMed ID: 15221006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a novel fusion gene MLL-MAML2 in secondary acute myelogenous leukemia and myelodysplastic syndrome with inv(11)(q21q23).
    Nemoto N; Suzukawa K; Shimizu S; Shinagawa A; Takei N; Taki T; Hayashi Y; Kojima H; Kawakami Y; Nagasawa T
    Genes Chromosomes Cancer; 2007 Sep; 46(9):813-9. PubMed ID: 17551948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program.
    Rice S; Jackson T; Crump NT; Fordham N; Elliott N; O'Byrne S; Fanego MDML; Addy D; Crabb T; Dryden C; Inglott S; Ladon D; Wright G; Bartram J; Ancliff P; Mead AJ; Halsey C; Roberts I; Milne TA; Roy A
    Nat Commun; 2021 Nov; 12(1):6905. PubMed ID: 34824279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ENL moiety of the childhood leukemia-associated MLL-ENL oncoprotein recruits human Polycomb 3.
    García-Cuéllar MP; Zilles O; Schreiner SA; Birke M; Winkler TH; Slany RK
    Oncogene; 2001 Jan; 20(4):411-9. PubMed ID: 11313972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ligand-independent FLT3 activation does not cooperate with MLL-AF4 to immortalize/transform cord blood CD34+ cells.
    Montes R; Ayllón V; Prieto C; Bursen A; Prelle C; Romero-Moya D; Real PJ; Navarro-Montero O; Chillón C; Marschalek R; Bueno C; Menendez P
    Leukemia; 2014 Mar; 28(3):666-74. PubMed ID: 24240202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.